Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority claimed from PCT/IB2014/059689external-prioritypatent/WO2014147526A1/en
Publication of MX2015013279ApublicationCriticalpatent/MX2015013279A/es
Publication of MX382075BpublicationCriticalpatent/MX382075B/es
La presente invención se refiere a las formulaciones de liberación sostenida oral de tofacitinib y sus sales aceptables farmacéuticas. Las formulaciones descriptas en la presente tienen características farmacocinéticas.
MX2015013279A2013-03-162014-03-12Forma de dosis orales de liberación sostenida de tofacitinib.
MX382075B
(es)